Evidence map›Paper›PMID 37809416›Full record

ArticleHeliyon2023

Plant extract-mediated synthesis Cobalt doping in zinc oxide nanoparticles and their

Nouf M Al-Enazi, Khawla Alsamhary, Fuad Ameen, Mansour Kha

RetractedOpen access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

  • Retraction · 2026-03-16Concerns/Issues about Referencing/Attributions · Investigation by Journal/Publisher · Objections by Author(s) · Unreliable Results and/or Conclusions ·
5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Nouf M Al-EnaziDepartment of Biology, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia.
Khawla AlsamharyDepartment of Biology, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia.
Fuad AmeenDepartment of Botany & Microbiology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Mansour KhaAntibacterial Materials R&D Centre, Huzhou Institute, Huzhou, Zhejiang, China.
Prince Sattam Bin Abdulaziz University · SAHuzhou University · CNKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this research, zinc oxide (ZnO) nanoparticles doped with different percentages of produced cobalt using the green synthesis method. ZnO nanoparticles showed good cellular and microbial toxicity due to their high surface-to-volume ratio. Adding cobalt metal to the nanostructure can lead to the appearance of a new feature. To investigate the effect of adding cobalt metal, synthesized ZnO nanoparticles containing 3 and 6% cobalt were synthesized using plant extract. The resulting nanostructures were characterized by a Raman spectroscopy, UV-Visible spectrometer, X-ray diffraction, and Field emission scanning electron microscopy. Ultimately, the synthesized samples' cytotoxicity and antimicrobial tests were performed. XRD confirmed the formation of a hexagonal wurtzite ZnO structure. XRD and electron imaging showed that doping resulted in a decrease in average crystal size. The results showed that with cobalt doping, the particle size decreased slightly. The cytotoxicity and antimicrobial effects results showed that in all three studies, cobalt doping leads to an increase in the toxicity of this nanostructure compared to non-doped nanoparticles.

Indexed as

AntimicrobialCytotoxicityDopedNanoparticlesNanostructure

Identifiers

PMID37809416
PMCPMC10558898
OpenAlexW4386280304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.